JPY 220.0
(0.0%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 50.02 Million JPY | 22332.74% |
2022 | 223 Thousand JPY | -99.55% |
2021 | 49.92 Million JPY | 18.45% |
2020 | 42.15 Million JPY | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 178 Thousand JPY | -99.64% |
2024 Q2 | 104 Thousand JPY | -41.57% |
2023 Q3 | 115.26 Million JPY | 32926.93% |
2023 FY | 50.02 Million JPY | 22332.74% |
2023 Q2 | 349 Thousand JPY | 56.5% |
2023 Q1 | 223 Thousand JPY | 0.0% |
2023 Q4 | 50.02 Million JPY | -56.6% |
2022 Q2 | - JPY | 0.0% |
2022 Q4 | 223 Thousand JPY | 0.0% |
2022 Q3 | - JPY | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
KOHJIN BIO CO LTD | 683.01 Million JPY | 92.676% |
PRISM BioLab Co.,LTD | 17.92 Million JPY | -179.017% |
GNI Group Ltd. | 2.33 Billion JPY | 97.854% |
Linical Co., Ltd. | - JPY | -Infinity% |
Trans Genic Inc. | 2.22 Billion JPY | 97.754% |
MEDINET Co., Ltd. | 67.48 Million JPY | 25.868% |
Soiken Holdings Inc. | 1.12 Billion JPY | 95.537% |
Cytori Cell Research Institute, Inc. | 103.53 Million JPY | 51.683% |
AnGes, Inc. | 1.61 Billion JPY | 96.904% |
OncoTherapy Science, Inc. | 73.99 Million JPY | 32.398% |
Nxera Pharma Co., Ltd. | 2.9 Billion JPY | 98.277% |
Immuno-Biological Laboratories Co., Ltd. | 321.91 Million JPY | 84.46% |
NanoCarrier Co., Ltd. | 184 Thousand JPY | -27087.5% |
Carna Biosciences, Inc. | 140.14 Million JPY | 64.304% |
CanBas Co., Ltd. | 728 Thousand JPY | -6771.566% |
D. Western Therapeutics Institute, Inc. | 87.86 Million JPY | 43.065% |
RaQualia Pharma Inc. | 147.93 Million JPY | 66.185% |
Chiome Bioscience Inc. | 64.1 Million JPY | 21.966% |
Kidswell Bio Corporation | 875.65 Million JPY | 94.287% |
PeptiDream Inc. | 2.4 Billion JPY | 97.919% |
Oncolys BioPharma Inc. | 5.34 Million JPY | -836.447% |
Ribomic Inc. | 2.27 Million JPY | -2099.868% |
SanBio Company Limited | - JPY | -Infinity% |
Healios K.K. | - JPY | -Infinity% |
BrightPath Biotherapeutics Co., Ltd. | 1.00 JPY | -5002499900.0% |
Kubota Pharmaceutical Holdings Co., Ltd. | 36 Million JPY | -38.958% |
Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
StemRIM | 29 Million JPY | -72.5% |
CellSource Co., Ltd. | 305.92 Million JPY | 83.648% |
FunPep Company Limited | 25.54 Million JPY | -95.862% |
Kringle Pharma, Inc. | 364.05 Million JPY | 86.259% |
Stella Pharma Corporation | 1.11 Billion JPY | 95.519% |
Noile-Immune Biotech Inc. | 20.9 Million JPY | -139.343% |
Cuorips Inc. | 1.04 Million JPY | -4696.261% |
K Pharma,Inc. | 10.79 Million JPY | -363.452% |
Takara Bio Inc. | 11.85 Billion JPY | 99.578% |
ReproCELL Incorporated | 248.14 Million JPY | 79.84% |
PhoenixBio Co., Ltd. | 450.58 Million JPY | 88.898% |
StemCell Institute Inc. | 42.26 Million JPY | -18.369% |
Japan Tissue Engineering Co., Ltd. | 228.56 Million JPY | 78.113% |
CellSeed Inc. | 46.19 Million JPY | -8.3% |